Skip to main content

Table 2 Demographic and clinical data of study group. Multiple symptoms were possible. Note that data were retrospectively recorded from medical records of patients; no structured interview was performed

From: Gene variants of the SLC2A5 gene encoding GLUT5, the major fructose transporter, do not contribute to clinical presentation of acquired fructose malabsorption

Demographic parameter Number/frequency
Gender (m/f) 6 (17%)/29 (83%)
Age (years); median (range) 36 (18–68)
Symptoms  
Abdominal pain 17 (48.6%)
Diarrhoea 12 (34.3%)
Meteorism 5 (14.3%)
Gastroesophageal reflux 5 (14.3%)
Irregular stool frequency 4 ((11.4)
Obstipation 3 (8.6%)
Haematochezia 2 (5.7%)
Not reported in detail 11 (31.4%)
Onset of symptoms  
Weeks to months 8 (22.9%)
Years 6 (17.1%)
Not recorded 21 (60.0%)
Serological assessment of coeliac disease  
Anti-deamidated gliadin IgG/IgA antibodies: negative 30/35 (85.7%)
Anti-tissue transglutaminase IgG/IgA: negative 4/35 (11.4%)
No information 1/35 (2.9%)